102 related articles for article (PubMed ID: 3818154)
1. Relationship between risk factors for breast cancer and hormonal status.
Hislop TG; Coldman AJ; Elwood JM; Skippen DH; Kan L
Int J Epidemiol; 1986 Dec; 15(4):469-76. PubMed ID: 3818154
[TBL] [Abstract][Full Text] [Related]
2. Reproductive and hormonal factors, family history, and breast cancer according to the hormonal receptor status.
Rosato V; Bosetti C; Negri E; Talamini R; Dal Maso L; Malvezzi M; Falcini F; Montella M; La Vecchia C
Eur J Cancer Prev; 2014 Sep; 23(5):412-7. PubMed ID: 23817433
[TBL] [Abstract][Full Text] [Related]
3. Relationship between estrogen receptors and risk factors of breast cancer in Japanese pre- and postmenopausal patients.
Nomura Y; Tashiro H; Hamada Y; Shigematsu T
Breast Cancer Res Treat; 1984; 4(1):37-43. PubMed ID: 6697010
[TBL] [Abstract][Full Text] [Related]
4. Estrogen receptor positive operable breast cancer: does menopausal status impact on HER2 and progesterone receptor status?
Wang N; Wang B; Wang Y; Hu J
Breast; 2011 Dec; 20(6):519-24. PubMed ID: 21700456
[TBL] [Abstract][Full Text] [Related]
5. Body weight and incidence of breast cancer defined by estrogen and progesterone receptor status--a meta-analysis.
Suzuki R; Orsini N; Saji S; Key TJ; Wolk A
Int J Cancer; 2009 Feb; 124(3):698-712. PubMed ID: 18988226
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for estrogen receptor-rich and estrogen receptor-poor breast cancers.
McTiernan A; Thomas DB; Johnson LK; Roseman D
J Natl Cancer Inst; 1986 Oct; 77(4):849-54. PubMed ID: 3463818
[TBL] [Abstract][Full Text] [Related]
7. Proportion of premenopausal and postmenopausal breast cancers attributable to known risk factors: Estimates from the E3N-EPIC cohort.
Dartois L; Fagherazzi G; Baglietto L; Boutron-Ruault MC; Delaloge S; Mesrine S; Clavel-Chapelon F
Int J Cancer; 2016 May; 138(10):2415-27. PubMed ID: 26756677
[TBL] [Abstract][Full Text] [Related]
8. Body weight at age 20 years, subsequent weight change and breast cancer risk defined by estrogen and progesterone receptor status--the Japan public health center-based prospective study.
Suzuki R; Iwasaki M; Inoue M; Sasazuki S; Sawada N; Yamaji T; Shimazu T; Tsugane S;
Int J Cancer; 2011 Sep; 129(5):1214-24. PubMed ID: 21064092
[TBL] [Abstract][Full Text] [Related]
9. Association between chronological change of reproductive factors and breast cancer risk defined by hormone receptor status: results from the Seoul Breast Cancer Study.
Chung S; Park SK; Sung H; Song N; Han W; Noh DY; Ahn SH; Yoo KY; Choi JY; Kang D
Breast Cancer Res Treat; 2013 Aug; 140(3):557-65. PubMed ID: 23901017
[TBL] [Abstract][Full Text] [Related]
10. The prevalence and significance of oestrogen receptor (ER) positivity in breast cancer at the University Hospital of the West Indies, Jamaica.
Alfred R; Chin SN; Williams E; Walters C; Barton EN; Shah D
West Indian Med J; 2012 Nov; 61(8):795-801. PubMed ID: 23757900
[TBL] [Abstract][Full Text] [Related]
11. Menopausal status does not predict Oncotype DX recurrence score.
Carr DN; Vera N; Sun W; Lee MC; Hoover S; Fulp W; Acs G; Laronga C
J Surg Res; 2015 Sep; 198(1):27-33. PubMed ID: 26095420
[TBL] [Abstract][Full Text] [Related]
12. Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies.
Collaborative Group on Hormonal Factors in Breast Cancer
Lancet Oncol; 2012 Nov; 13(11):1141-51. PubMed ID: 23084519
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for hormone receptor-defined breast cancer in postmenopausal women.
Rosenberg LU; Einarsdóttir K; Friman EI; Wedrén S; Dickman PW; Hall P; Magnusson C
Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2482-8. PubMed ID: 17164374
[TBL] [Abstract][Full Text] [Related]
14. Reproductive factors and breast cancer risk according to joint estrogen and progesterone receptor status: a meta-analysis of epidemiological studies.
Ma H; Bernstein L; Pike MC; Ursin G
Breast Cancer Res; 2006; 8(4):R43. PubMed ID: 16859501
[TBL] [Abstract][Full Text] [Related]
15. A comparison of epidemiological characteristics in breast cancer patients and normal women in Great Britain and Japan: results of a prospective study.
Chaudary MA; Hayward JL; Bulbrook RD; Yoshida M; Miura S; Murai JT; Takatani O
Breast Cancer Res Treat; 1991 May; 18 Suppl 1():S19-22. PubMed ID: 1873552
[TBL] [Abstract][Full Text] [Related]
16. Combined effect of childbearing, menstrual events, and body size on age-specific breast cancer risk.
Kampert JB; Whittemore AS; Paffenbarger RS
Am J Epidemiol; 1988 Nov; 128(5):962-79. PubMed ID: 3189296
[TBL] [Abstract][Full Text] [Related]
17. Body size and breast cancer prognosis in relation to hormone receptor and menopausal status: a meta-analysis.
Niraula S; Ocana A; Ennis M; Goodwin PJ
Breast Cancer Res Treat; 2012 Jul; 134(2):769-81. PubMed ID: 22562122
[TBL] [Abstract][Full Text] [Related]
18. Genetic and environmental predictors, endogenous hormones and growth factors, and risk of estrogen receptor-positive breast cancer in Japanese women.
Yoshimoto N; Nishiyama T; Toyama T; Takahashi S; Shiraki N; Sugiura H; Endo Y; Iwasa M; Fujii Y; Yamashita H
Cancer Sci; 2011 Nov; 102(11):2065-72. PubMed ID: 21790896
[TBL] [Abstract][Full Text] [Related]
19. Alcohol and postmenopausal breast cancer risk defined by estrogen and progesterone receptor status: a prospective cohort study.
Suzuki R; Ye W; Rylander-Rudqvist T; Saji S; Colditz GA; Wolk A
J Natl Cancer Inst; 2005 Nov; 97(21):1601-8. PubMed ID: 16264180
[TBL] [Abstract][Full Text] [Related]
20. An association study of established breast cancer reproductive and lifestyle risk factors with tumour subtype defined by the prognostic 70-gene expression signature (MammaPrint
Makama M; Drukker CA; Rutgers EJT; Slaets L; Cardoso F; Rookus MA; Tryfonidis K; Van't Veer LJ; Schmidt MK
Eur J Cancer; 2017 Apr; 75():5-13. PubMed ID: 28214658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]